share_log

Do CRH's (NYSE:CRH) Earnings Warrant Your Attention?

Do CRH's (NYSE:CRH) Earnings Warrant Your Attention?

CRH(紐約證券交易所代碼:CRH)的收益值得你注意嗎?
Simply Wall St ·  01/23 08:30

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Sometimes these stories can cloud the minds of investors, leading them to invest with their emotions rather than on the merit of good company fundamentals. While a well funded company may sustain losses for years, it will need to generate a profit eventually, or else investors will move on and the company will wither away.

許多投資者,尤其是那些沒有經驗的投資者,通常會購買有好故事的公司的股票,即使這些公司虧損。有時,這些故事可能會給投資者的思想蒙上陰影,導致他們用自己的情感進行投資,而不是根據良好的公司基本面的優點進行投資。雖然資金充足的公司可能會遭受多年的損失,但它最終需要創造利潤,否則投資者將繼續前進,公司將萎縮。

In contrast to all that, many investors prefer to focus on companies like CRH (NYSE:CRH), which has not only revenues, but also profits. Now this is not to say that the company presents the best investment opportunity around, but profitability is a key component to success in business.

與此形成鮮明對比的是,許多投資者更願意關注像CRH(紐約證券交易所代碼:CRH)這樣的公司,該公司不僅有收入,還有利潤。現在,這並不是說該公司提供了最好的投資機會,但盈利能力是業務成功的關鍵因素。

View our latest analysis for CRH

查看我們對CRH的最新分析

CRH's Earnings Per Share Are Growing

CRH的每股收益正在增長

If you believe that markets are even vaguely efficient, then over the long term you'd expect a company's share price to follow its earnings per share (EPS) outcomes. Therefore, there are plenty of investors who like to buy shares in companies that are growing EPS. It certainly is nice to see that CRH has managed to grow EPS by 31% per year over three years. If growth like this continues on into the future, then shareholders will have plenty to smile about.

如果你認爲市場的效率甚至含糊不清,那麼從長遠來看,你預計公司的股價將遵循其每股收益(EPS)的結果。因此,有很多投資者喜歡購買每股收益不斷增長的公司的股票。很高興看到CRH在三年內設法將每股收益增長31%。如果這樣的增長持續到未來,那麼股東們將有很多值得微笑的地方。

It's often helpful to take a look at earnings before interest and tax (EBIT) margins, as well as revenue growth, to get another take on the quality of the company's growth. CRH maintained stable EBIT margins over the last year, all while growing revenue 9.1% to US$34b. That's progress.

查看利息和稅前收益(EBIT)利潤率以及收入增長通常會很有幫助,這樣可以重新了解公司的增長質量。去年,CRH保持了穩定的息稅前利潤率,同時收入增長了9.1%,達到340億美元。這就是進步。

You can take a look at the company's revenue and earnings growth trend, in the chart below. To see the actual numbers, click on the chart.

您可以在下表中查看該公司的收入和收益增長趨勢。要查看實際數字,請單擊圖表。

earnings-and-revenue-history
NYSE:CRH Earnings and Revenue History January 23rd 2024
紐約證券交易所:CRH 收益和收入歷史記錄 2024 年 1 月 23 日

You don't drive with your eyes on the rear-view mirror, so you might be more interested in this free report showing analyst forecasts for CRH's future profits.

你開車時不要注視後視鏡,因此你可能會對這份顯示分析師對CRH未來利潤預測的免費報告更感興趣。

Are CRH Insiders Aligned With All Shareholders?

CRH內部人士是否與所有股東保持一致?

Investors are always searching for a vote of confidence in the companies they hold and insider buying is one of the key indicators for optimism on the market. That's because insider buying often indicates that those closest to the company have confidence that the share price will perform well. Of course, we can never be sure what insiders are thinking, we can only judge their actions.

投資者一直在尋求對他們所持有的公司的信任票,而內幕買入是市場樂觀情緒的關鍵指標之一。那是因爲內幕買盤通常表明與公司關係最密切的人有信心股價會表現良好。當然,我們永遠無法確定內部人士在想什麼,我們只能判斷他們的行爲。

Any way you look at it CRH shareholders can gain quiet confidence from the fact that insiders shelled out US$749k to buy stock, over the last year. And when you consider that there was no insider selling, you can understand why shareholders might believe that there are brighter days ahead. It is also worth noting that it was Independent Non-Executive Director Richard Fearon who made the biggest single purchase, worth US$614k, paying US$61.37 per share.

無論你怎麼看,去年內部人士花了74.9萬美元購買股票,CRH股東都可以從中獲得沉默的信心。而且,當你考慮到沒有內幕拋售時,你就能理解爲什麼股東會認爲未來會有更美好的日子。還值得注意的是,獨立非執行董事理查德·費倫進行了最大的單筆收購,價值614萬美元,每股支付61.37美元。

Should You Add CRH To Your Watchlist?

你應該將 CRH 添加到你的關注列表嗎?

If you believe that share price follows earnings per share you should definitely be delving further into CRH's strong EPS growth. The growth rate should be enticing enough to consider researching the company, and the insider buying is a great added bonus. In essence, your time will not be wasted checking out CRH in more detail. If you think CRH might suit your style as an investor, you could go straight to its annual report, or you could first check our discounted cash flow (DCF) valuation for the company.

如果你認爲股價跟隨每股收益,那麼你肯定應該進一步研究CRH的強勁每股收益增長。增長率應該足夠誘人,足以考慮對公司進行研究,而內幕收購是一個很好的額外好處。從本質上講,您的時間不會浪費在更詳細地查看CRH上。如果您認爲CRH可能適合您作爲投資者的風格,則可以直接查看其年度報告,也可以先查看我們對該公司的折扣現金流(DCF)估值。

The good news is that CRH is not the only growth stock with insider buying. Here's a list of growth-focused companies in the US with insider buying in the last three months!

好消息是,CRH並不是唯一擁有內幕買盤的成長股。以下是過去三個月內有內幕買盤的美國以增長爲重點的公司名單!

Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.

請注意,本文中討論的內幕交易是指相關司法管轄區內應報告的交易。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論